JP2022536951A5 - - Google Patents

Info

Publication number
JP2022536951A5
JP2022536951A5 JP2021575283A JP2021575283A JP2022536951A5 JP 2022536951 A5 JP2022536951 A5 JP 2022536951A5 JP 2021575283 A JP2021575283 A JP 2021575283A JP 2021575283 A JP2021575283 A JP 2021575283A JP 2022536951 A5 JP2022536951 A5 JP 2022536951A5
Authority
JP
Japan
Prior art keywords
composition
days
level
cyclic
polyribonucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021575283A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536951A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/038835 external-priority patent/WO2020257727A1/en
Publication of JP2022536951A publication Critical patent/JP2022536951A/ja
Publication of JP2022536951A5 publication Critical patent/JP2022536951A5/ja
Priority to JP2025272525A priority Critical patent/JP2026040556A/ja
Withdrawn legal-status Critical Current

Links

JP2021575283A 2019-06-19 2020-06-19 環状ポリリボヌクレオチドを投与する方法 Withdrawn JP2022536951A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025272525A JP2026040556A (ja) 2019-06-19 2025-12-22 環状ポリリボヌクレオチドを投与する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962863725P 2019-06-19 2019-06-19
US62/863,725 2019-06-19
PCT/US2020/038835 WO2020257727A1 (en) 2019-06-19 2020-06-19 Methods of dosing circular polyribonucleotides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025272525A Division JP2026040556A (ja) 2019-06-19 2025-12-22 環状ポリリボヌクレオチドを投与する方法

Publications (2)

Publication Number Publication Date
JP2022536951A JP2022536951A (ja) 2022-08-22
JP2022536951A5 true JP2022536951A5 (https=) 2023-06-27

Family

ID=71842849

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021575283A Withdrawn JP2022536951A (ja) 2019-06-19 2020-06-19 環状ポリリボヌクレオチドを投与する方法
JP2025272525A Pending JP2026040556A (ja) 2019-06-19 2025-12-22 環状ポリリボヌクレオチドを投与する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025272525A Pending JP2026040556A (ja) 2019-06-19 2025-12-22 環状ポリリボヌクレオチドを投与する方法

Country Status (10)

Country Link
US (2) US20220296729A1 (https=)
EP (1) EP3987038A1 (https=)
JP (2) JP2022536951A (https=)
KR (1) KR20220024647A (https=)
CN (1) CN114096674A (https=)
AU (1) AU2020296190A1 (https=)
CA (1) CA3140594A1 (https=)
IL (1) IL288983A (https=)
MA (1) MA56538A (https=)
WO (1) WO2020257727A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111819185A (zh) 2017-12-15 2020-10-23 旗舰创业创新第六有限责任公司 包含环状多核糖核苷酸的组合物及其用途
WO2020198403A2 (en) 2019-03-25 2020-10-01 Flagship Pioneering Innovations Vi, Llc Compositions comprising modified circular polyribonucleotides and uses thereof
CN114981409A (zh) 2019-09-03 2022-08-30 美洛德生物医药公司 用于基因组整合的方法和组合物
US20230203192A1 (en) * 2020-05-20 2023-06-29 Flagship Pioneering, Inc. Compositions and methods for producing human polyclonal antibodies
BR112023023642A2 (pt) 2021-05-11 2024-01-30 Myeloid Therapeutics Inc Métodos e composições para integração genômica
MX2024003262A (es) 2021-09-17 2024-06-19 Flagship Pioneering Innovations Vi Llc Composiciones y metodos para producir poliribonucleotidos circulares.
KR20240118174A (ko) 2021-12-17 2024-08-02 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 변성 조건 하에서의 원형 rna의 풍부화를 위한 방법
CN121057577A (zh) 2023-01-27 2025-12-02 赛欧生物医药股份有限公司 经修饰的脂质组合物及其用途
CN116870004B (zh) * 2023-02-24 2025-10-21 中南大学 以brd7为靶点在防治自身免疫性疾病药物中的应用
CN117070564B (zh) * 2023-03-30 2024-05-10 安可来(重庆)生物医药科技有限公司 一种用于合成环形rna的质粒及其构建方法与一种环形rna及其体外合成方法
CN120241980A (zh) * 2023-12-29 2025-07-04 复旦大学 一种基于环状rna的现货型体内原位car与肿瘤疫苗联用的免疫治疗技术及其应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266684A (en) 1988-05-02 1993-11-30 The Reagents Of The University Of California Peptide mixtures
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
AU649066B2 (en) 1990-07-25 1994-05-12 Syngene, Inc. Circular extension for generating multiple nucleic acid complements
US5426180A (en) 1991-03-27 1995-06-20 Research Corporation Technologies, Inc. Methods of making single-stranded circular oligonucleotides
US5639603A (en) 1991-09-18 1997-06-17 Affymax Technologies N.V. Synthesizing and screening molecular diversity
US5770358A (en) 1991-09-18 1998-06-23 Affymax Technologies N.V. Tagged synthetic oligomer libraries
JPH07502898A (ja) 1992-01-13 1995-03-30 デューク・ユニバーシティー 酵素rna分子
US5541061A (en) 1992-04-29 1996-07-30 Affymax Technologies N.V. Methods for screening factorial chemical libraries
US5288514A (en) 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5721099A (en) 1992-10-01 1998-02-24 Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
US5565324A (en) 1992-10-01 1996-10-15 The Trustees Of Columbia University In The City Of New York Complex combinatorial chemical libraries encoded with tags
US5773244A (en) 1993-05-19 1998-06-30 Regents Of The University Of California Methods of making circular RNA
US5440016A (en) 1993-06-18 1995-08-08 Torrey Pines Institute For Molecular Studies Peptides of the formula (KFmoc) ZZZ and their uses
US5593853A (en) 1994-02-09 1997-01-14 Martek Corporation Generation and screening of synthetic drug libraries
US5688997A (en) 1994-05-06 1997-11-18 Pharmacopeia, Inc. Process for preparing intermediates for a combinatorial dihydrobenzopyran library
US5525735A (en) 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
US5549974A (en) 1994-06-23 1996-08-27 Affymax Technologies Nv Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
US5463564A (en) 1994-09-16 1995-10-31 3-Dimensional Pharmaceuticals, Inc. System and method of automatically generating chemical compounds with desired properties
US5688696A (en) 1994-12-12 1997-11-18 Selectide Corporation Combinatorial libraries having a predetermined frequency of each species of test compound
WO1997000887A1 (en) 1995-06-21 1997-01-09 Martek Biosciences Corporation Combinatorial libraries of labeled biochemical compounds and methods for producing same
US5766903A (en) * 1995-08-23 1998-06-16 University Technology Corporation Circular RNA and uses thereof
US5731423A (en) 1996-03-21 1998-03-24 Transcell Technologies, Inc. Process for preparing sulfoxides
US6429301B1 (en) 1998-04-17 2002-08-06 Whitehead Institute For Biomedical Research Use of a ribozyme to join nucleic acids and peptides
US6210931B1 (en) 1998-11-30 2001-04-03 The United States Of America As Represented By The Secretary Of Agriculture Ribozyme-mediated synthesis of circular RNA
EP2447370B1 (en) 2001-09-28 2018-07-18 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. MicroRNA molecules
US7683036B2 (en) 2003-07-31 2010-03-23 Regulus Therapeutics Inc. Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
JP5296328B2 (ja) 2007-05-09 2013-09-25 独立行政法人理化学研究所 1本鎖環状rnaおよびその製造方法
WO2010084371A1 (en) 2009-01-26 2010-07-29 Mitoprod Novel circular interfering rna molecules
WO2015034925A1 (en) * 2013-09-03 2015-03-12 Moderna Therapeutics, Inc. Circular polynucleotides
US10407683B2 (en) * 2014-07-16 2019-09-10 Modernatx, Inc. Circular polynucleotides
EP4219532A3 (en) * 2015-06-05 2023-08-16 Dana-Farber Cancer Institute, Inc. Compositions and methods for transient gene therapy with enhanced stability
AU2018251187B2 (en) * 2017-04-14 2024-03-28 Dana-Farber Cancer Institute, Inc. Compositions and methods for transient gene therapy with enhanced stability
US20200131498A1 (en) * 2017-06-14 2020-04-30 Modernatx, Inc. Polynucleotides encoding methylmalonyl-coa mutase
CN111819185A (zh) 2017-12-15 2020-10-23 旗舰创业创新第六有限责任公司 包含环状多核糖核苷酸的组合物及其用途
CN112399860B (zh) * 2018-06-06 2024-08-16 麻省理工学院 用于在真核细胞中翻译的环状rna
BR112021023411A2 (pt) * 2019-05-22 2022-02-01 Massachusetts Inst Technology Composições e métodos de rna circular

Similar Documents

Publication Publication Date Title
JP2022536951A5 (https=)
Pituru et al. A review on the biocompatibility of PMMA-based dental materials for interim prosthetic restorations with a glimpse into their modern manufacturing techniques
Zanza et al. Cytokine storm in COVID-19: immunopathogenesis and therapy
Abad-Coronel et al. Adhesive systems used in indirect restorations cementation: review of the literature
ES3001108T3 (es) Moléculas quiméricas y usos de las mismas
Zhang et al. Extracellular vesicles-loaded fibrin gel supports rapid neovascularization for dental pulp regeneration
JP6728047B2 (ja) 治療方法及び組成物
Guo et al. Monocyte chemotactic protein-1 promotes the myocardial homing of mesenchymal stem cells in dilated cardiomyopathy
Kaga et al. Protective effects of GIC and S-PRG filler restoratives on demineralization of bovine enamel in lactic acid solution
SA515360253B1 (ar) أجسام مضادة مُميزة لألفا سينوكلين
Zhang et al. Developing a new generation of therapeutic dental polymers to inhibit oral biofilms and protect teeth
JPH01501939A (ja) 免疫抑制ペプチドおよび使用法
CN118496316B (zh) 一种高活性改善学习记忆力抗氧化核桃衍生肽及其应用
Awad et al. Evaluation of the bond strength and cytotoxicity of alkasite restorative material
Liang et al. Recent advances in quaternary ammonium monomers for dental applications
Chuang et al. Dentin sialoprotein/phosphophoryn (DSP/PP) as bio-inductive materials for direct pulp capping
Alshabib et al. Mechanical stability of self-adhesive/ion-releasing resin composites
Abouel Maaty et al. Peri-implant soft tissue in contact with Zirconium/Titanium abutments from histological and biological perspectives: a concise review
Alsaadawi et al. Shear bond strength and fluoride release of a universal adhesive: an in-vitro study on primary teeth
Kim et al. Comparison of luting cement solubility: A narrative review
Bănuț Oneț et al. Adhesion of flowable resin composites in simulated wedge-shaped cervical lesions: An in vitro pilot study
Sahli et al. Comparison of class II bulk-fill, self-adhesive composites, alkasite, and high-viscosity glass ionomer restorations in terms of marginal and internal adaptation
KR102720867B1 (ko) 변형된 egf 단백질 및 이를 유효성분으로 포함하는 피부 상태 개선용 화장료 조성물
JPH10506538A (ja) Gp130に全く結合することができないヒトインターロイキン−6の拮抗薬、および医薬化合物の製造におけるそれらの使用
Vergano et al. Bond strength stability of different dual-curing adhesive cements towards CAD-CAM resin nanoceramic: an in vitro study